SI is a promoter and a very successful promoter that has raised over $1B for MSB.
An FDA approval means the company moves into a commercialisation phase and needs different skill. Particularly amongst its executive team & the board.
SI & the BOD signed off on the quarterly released yesterday this includes MSB's financial position which signals they are virtually certain of an FDA approval (& this is consistent with insider activity over 2024).
Ecool is consistently pushing a rights issue & FDA failure notwithstanding board communications - this implies another agenda. GG will not abandon his $200mm investment if by chance there is another CRL GG will use it as an opportunity to further exert his influence.
MSB Price at posting:
$1.32 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)